Mabpharm Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-138.00
-231.00
-245.00
-351.00
-207.00
-229.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
37.00
200.00
95.00
34.00
-29.00
47.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-8.00
59.00
-67.00
-240.00
-155.00
-164.00
Cash Flow from Investing Activities
-64.00
-4.00
-122.00
-218.00
160.00
-468.00
Cash Flow from Financing Activities
24.00
98.00
132.00
-18.00
-85.00
1,056.00
Net Cash Inflow / Outflow
-48.00
154.00
-55.00
-486.00
-116.00
442.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
1.00
-7.00
-36.00
19.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Mabpharm Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-138.723187976909
429.577971674687
-567.00
-132.29%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
37.7884535828055
399.51646092205
-362.00
-90.54%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-8.7941395865531
1827.8060656821
-1,835.00
-100.48%
Cash Flow from Investing Activities
-64.3692853056432
-2036.1031456938
1,972.00
96.84%
Cash Flow from Financing Activities
24.7268089521551
-90.780655932593
114.00
127.24%
Net Cash Inflow / Outflow
-48.4214368062461
-303.330661833905
255.00
84.04%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.0151791337950615
-4.25292588960687
4.00
100.36%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -114.70% vs 188.09% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-8.79
59.83
-114.70%






